Stockreport

BioCardia Reports Completion of Low Dose Cohort Enrollment for CardiALLO Phase I/II Clinical Trial of BCDA-03 Allogeneic Mesenchymal Stem Cells to Treat Ischemic Heart Failure of Reduced E...

BioCardia, Inc.  (BCDA) 
PDF BioCardia, Inc. Thu, February 13, 2025 at 2:30 PM GMT+1 7 min read In This Article BCDA BCDAW BioCardia, Inc. Focus on Patients with Elevated Markers of H [Read more]